Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ALRS.ME Stock Summary
In the News
ALRS.ME Financial details
Company Rating
Strong Buy
Market Cap
492.27B
Income
100.18B
Revenue
323.18B
Book val./share
52.54
Cash/share
18.5
Dividend
3.77
Dividend %
5.64%
Employees
32K
Optionable
No
Shortable
Yes
Earnings
14 May 2024
P/E
5.3
Forward P/E
-
PEG
-245.74
P/S
1.51
P/B
2.16
P/C
3.61
P/FCF
4.65
Quick Ratio
1.15
Current Ratio
3.14
Debt / Equity
0.34
LT Debt / Equity
0.2
-
-
EPS (TTM)
13.88
EPS next Y
-
EPS next Q
-
EPS this Y
-15.17%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
6.53%
Revenue last 5Y
6.73%
Revenue Q/Q
8.27%
EPS Q/Q
-24.8%
-
-
-
-
SMA20
-
SMA50
-4.69%
SMA100
-
Inst Own
-
Inst Trans
-
ROA
21%
ROE
37%
ROC
0.31%
Gross Margin
47%
Oper. Margin
35%
Profit Margin
28%
Payout
145%
Shs Outstand
7.36B
Shs Float
2.94B
-
-
-
-
Target Price
-
52W Range
64.95-77.28
52W High
-13.19%
52W Low
+4.44%
RSI
39
Rel Volume
-
Avg Volume
-
Volume
4.64M
Perf Week
8%
Perf Month
13.19%
Perf Quarter
-
Perf Half Y
0%
-
-
-
-
Beta
0.532
-
-
Volatility
2.6%, 1.49%
Prev Close
12.72%
Price
66.84
Change
13.87%
ALRS.ME Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 32.3 | 30.12 | 45.34 | 40.96 | 44.72 | |
Net income per share | 8.6 | 4.41 | 12.61 | 13.91 | 11.8 | |
Operating cash flow per share | 9.37 | 13.38 | 17.31 | 12.25 | 9.13 | |
Free cash flow per share | 6.6 | 11.02 | 14.68 | 6.58 | 0.3 | |
Cash per share | 5.22 | 18.95 | 8.51 | 13.31 | 13.76 | |
Book value per share | 35.15 | 36.65 | 31 | 44.67 | 52.94 | |
Tangible book value per share | 34.45 | 36.1 | 30.38 | 44.12 | 52.35 | |
Share holders equity per share | 35.15 | 36.65 | 31 | 44.67 | 52.94 | |
Interest debt per share | 17.5 | 24.58 | 18.02 | 15.26 | 19.54 | |
Market cap | 607.85B | 710.22B | 884.95B | 557.39B | 557.39B | |
Enterprise value | 711.82B | 791.19B | 977.95B | 636.13B | 656.36B | |
P/E ratio | 9.8 | 22.35 | 9.73 | 5.55 | 6.55 | |
Price to sales ratio | 2.61 | 3.27 | 2.71 | 1.89 | 1.73 | |
POCF ratio | 9 | 7.36 | 7.09 | 6.31 | 8.46 | |
PFCF ratio | 12.77 | 8.94 | 8.36 | 11.74 | 254.87 | |
P/B Ratio | 2.4 | 2.69 | 3.96 | 1.73 | 1.46 | |
PTB ratio | 2.4 | 2.69 | 3.96 | 1.73 | 1.46 | |
EV to sales | 3.06 | 3.64 | 2.99 | 2.15 | 2.03 | |
Enterprise value over EBITDA | 5.84 | 10.48 | 6.48 | 4.22 | 4.61 | |
EV to operating cash flow | 10.54 | 8.2 | 7.83 | 7.2 | 9.97 | |
EV to free cash flow | 14.96 | 9.96 | 9.24 | 13.4 | 300.12 | |
Earnings yield | 0.1 | 0.04 | 0.1 | 0.18 | 0.15 | |
Free cash flow yield | 0.08 | 0.11 | 0.12 | 0.09 | 0 | |
Debt to equity | 0.46 | 0.64 | 0.55 | 0.33 | 0.35 | |
Debt to assets | 0.27 | 0.32 | 0.29 | 0.2 | 0.23 | |
Net debt to EBITDA | 0.85 | 1.07 | 0.62 | 0.52 | 0.69 | |
Current ratio | 2.78 | 2.81 | 3.14 | 4.06 | 2.85 | |
Interest coverage | 10.96 | 5.54 | 15.47 | 24.9 | 19.21 | |
Income quality | 0.83 | 2.19 | 1.07 | 0.7 | 0.61 | |
Dividend Yield | 0.09 | 0.03 | 0.15 | 0 | 0.05 | |
Payout ratio | 0.92 | 0.6 | 1.45 | 0 | 0.32 | |
Sales general and administrative to revenue | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Capex to operating cash flow | -0.3 | -0.18 | -0.15 | -0.46 | -0.97 | |
Capex to revenue | -0.09 | -0.08 | -0.06 | -0.14 | -0.2 | |
Capex to depreciation | -0.81 | -0.72 | -0.78 | -1.78 | -2.2 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 82.49 | 60.3 | 93.8 | 118.25 | 118.57 | |
ROIC | 0.2 | 0.09 | 0.26 | 0.22 | 0.16 | |
Return on tangible assets | 0.15 | 0.06 | 0.22 | 0.19 | 0.14 | |
Graham Net | -9.37 | -7.09 | -11.7 | -4.94 | -3.41 | |
Working capital | 114.55B | 174.6B | 114.01B | 190.43B | 193.01B | |
Tangible asset value | 248.38B | 260.23B | 219.04B | 318.25B | 377.58B | |
Net current asset value | 2.6B | 17.46B | -32.86B | 54.24B | 82.63B | |
Invested capital | 0.46 | 0.64 | 0.55 | 0.33 | 0.35 | |
Average receivables | 6.85B | 11.52B | 9.17B | 4.51B | 0 | |
Average payables | 6.39B | 6.26B | 7.02B | 7.63B | 9.17B | |
Average inventory | 106.96B | 119.76B | 106.85B | 114.45B | 157.61B | |
Days sales outstanding | 21.47 | 15.69 | 10.06 | 0 | 0 | |
Days payables outstanding | 19.4 | 18.92 | 16.56 | 17.26 | 22.65 | |
Days of inventory on hand | 368.1 | 365.05 | 200.08 | 312.63 | 375.25 | |
Receivables turnover | 17 | 23.27 | 36.28 | 0 | 0 | |
Payables turnover | 18.81 | 19.29 | 22.04 | 21.15 | 16.11 | |
Inventory turnover | 0.99 | 1 | 1.82 | 1.17 | 0.97 | |
ROE | 0.24 | 0.12 | 0.41 | 0.31 | 0.22 | |
Capex per share | -2.77 | -2.36 | -2.63 | -5.67 | -8.83 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2021-06-30 | 2021-09-30 | 2021-12-31 | 2022-06-30 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 12.82 | 10.49 | 9.64 | 11.85 | 12.83 | |
Net income per share | 4.17 | 3.46 | 1.66 | 5 | 3.76 | |
Operating cash flow per share | 2.28 | 4.14 | 3.24 | 0 | 0 | |
Free cash flow per share | 1.66 | 3.4 | 2.31 | 0 | 0 | |
Cash per share | 21.45 | 16.38 | 8.5 | 0 | 18.5 | |
Book value per share | 34.65 | 29.32 | 30.99 | 0 | 52.54 | |
Tangible book value per share | 34.6 | 29.27 | 30.37 | 0 | 52.33 | |
Share holders equity per share | 34.65 | 29.32 | 30.99 | 0 | 52.54 | |
Interest debt per share | 17.54 | 17.84 | 17.27 | 0 | 17.98 | |
Market cap | 966.09B | 960.22B | 885.13B | 557.39B | 557.39B | |
Enterprise value | 1026.72B | 1037.18B | 978.14B | 0 | 653.92B | |
P/E ratio | 8.03 | 9.62 | 18.45 | 3.86 | 5.14 | |
Price to sales ratio | 10.45 | 12.69 | 12.73 | 6.52 | 6.02 | |
POCF ratio | 58.8 | 32.12 | 37.82 | 0 | 0 | |
PFCF ratio | 80.78 | 39.2 | 53.03 | 0 | 0 | |
P/B Ratio | 3.87 | 4.54 | 3.96 | 0 | 1.47 | |
PTB ratio | 3.87 | 4.54 | 3.96 | 0 | 1.47 | |
EV to sales | 11.11 | 13.71 | 14.06 | 0 | 7.07 | |
Enterprise value over EBITDA | 21.99 | 27.36 | 34.63 | 0 | 18.51 | |
EV to operating cash flow | 62.49 | 34.7 | 41.79 | 0 | 0 | |
EV to free cash flow | 85.85 | 42.34 | 58.6 | 0 | 0 | |
Earnings yield | 0.03 | 0.03 | 0.01 | 0.06 | 0.05 | |
Free cash flow yield | 0.01 | 0.03 | 0.02 | 0 | 0 | |
Debt to equity | 0.5 | 0.6 | 0.55 | 0 | 0.34 | |
Debt to assets | 0.24 | 0.27 | 0.29 | 0 | 0.22 | |
Net debt to EBITDA | 1.3 | 2.03 | 3.29 | 0 | 2.73 | |
Current ratio | 2.1 | 1.76 | 3.14 | 0 | 3.22 | |
Interest coverage | 21.4 | 18.8 | 8.79 | 11.94 | 21.2 | |
Income quality | 0.42 | 0.96 | 1.4 | 0 | 0 | |
Dividend Yield | 0 | 0.07 | 0.07 | 0 | 0 | |
Payout ratio | 0 | 2.75 | 5.28 | 0 | 0 | |
Sales general and administrative to revenue | 0.01 | 0.02 | 0.02 | 0.02 | 0.01 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0.01 | 0 | 0 | |
Capex to operating cash flow | -0.27 | -0.18 | -0.29 | 0 | 0 | |
Capex to revenue | -0.05 | -0.07 | -0.1 | 0 | 0 | |
Capex to depreciation | -0.75 | -0.92 | -1.04 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 57.02 | 47.78 | 34.06 | 0 | 66.68 | |
ROIC | 0.08 | 0.07 | 0.04 | 0 | 0.06 | |
Return on tangible assets | 0.06 | 0.05 | 0.03 | 0 | 0.05 | |
Graham Net | -8.33 | -13.64 | -12.64 | 0 | 1.77 | |
Working capital | 140.46B | 100.32B | 114.01B | 0 | 210.28B | |
Tangible asset value | 249.45B | 211.09B | 219.04B | 0 | 377.46B | |
Net current asset value | 8.23B | -32.27B | -32.86B | 0 | 97.89B | |
Invested capital | 0.5 | 0.6 | 0.55 | 0 | 0.34 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 6.78B | 6.47B | 7.25B | 0 | 0 | |
Average inventory | 92.92B | 92.67B | 95.46B | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 15.39 | |
Days payables outstanding | 13.37 | 15.26 | 18.11 | 0 | 19.58 | |
Days of inventory on hand | 189.56 | 220.77 | 218.71 | 0 | 284.04 | |
Receivables turnover | 0 | 0 | 0 | 0 | 5.85 | |
Payables turnover | 6.73 | 5.9 | 4.97 | 0 | 4.6 | |
Inventory turnover | 0.47 | 0.41 | 0.41 | 0 | 0.32 | |
ROE | 0.12 | 0.12 | 0.05 | 0 | 0.07 | |
Capex per share | -0.62 | -0.75 | -0.93 | 0 | 0 |
ALRS.ME Frequently Asked Questions
What is Public Joint Stock Company ALROSA stock symbol ?
Public Joint Stock Company ALROSA is a RU stock and trading under the symbol ALRS.ME
What is Public Joint Stock Company ALROSA stock quote today ?
Public Joint Stock Company ALROSA stock price is $66.84 today.
Is Public Joint Stock Company ALROSA stock public?
Yes, Public Joint Stock Company ALROSA is a publicly traded company.